DOI RECORD
Population Pharmacokinetics and Exposure–response Analysis of Durvalumab in Patients with Limited-stage Small-cell Lung Cancer in the Phase 3 ADRIATIC Study
DOI10.1208/s12248-026-01295-y
PublisherSpringer Science and Business Media LLC
Journal / SourceThe AAPS Journal
Published2026-09-28
Metadata Deposited2026-09-28 (updated: 2026-09-29)
Subject—
Languageen
ISSN1550-7416
Typejournal-article
Volume / Issue / Pages28 / 6 / —
Citations0
References deposited33
Access / license metadataOpen license identified License 1 ↗A reuse license does not by itself establish whether the full text is freely readable.
Go to Main Website